We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MURFU market cap is 245.4M. The company's latest EPS is USD -0.4037 and P/E is -41.74.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -407k | -3.45M | -895k | -2.96M | -3.14M |
Net Income | -343k | -2.09M | -3.74M | -3.55M | -5.38M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -4k | -1.2M | -5.26M |
Net Income | -4k | 399k | -6.06M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Total Assets | 23.69M | 12.02M | 7.22M | 4.92M | 3.31M |
Total Liabilities | 6.66M | 13.1M | 7.68M | 8.02M | 8.77M |
Total Equity | -6.07M | -1.08M | -457k | -3.1M | -5.46M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 213k | 137.52M | 7.22M |
Total Liabilities | 192k | 5.05M | 7.68M |
Total Equity | 21k | -4.3M | -457k |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Operating | -1.22M | -2.92M | -7.73M | -2.36M | -3.87M |
Investing | 114.47M | 228k | 725k | N/A | -224k |
Financing | -113.32M | 11.34M | 10.93M | N/A | 113k |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Operating | -6k | -1.31M | -7.73M |
Investing | N/A | -134.9M | 725k |
Financing | 55k | 136.5M | 10.93M |
Market Cap | 245.4M |
Price to Earnings Ratio | -41.74 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 59.77 |
Price to Book Ratio | -553.06 |
Dividend Yield | - |
Shares Outstanding | 15M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 3.38 (18.95%) |
Company Name | Murphy Canyon Acquisition Corporation |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.conduitpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions